Navigation Links
Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results
Date:3/12/2009

- Year end cash position improved through non core divestitures -

- Caliper signs extension of $25 million credit facility through November 2010 -

- Non-cash restructuring and goodwill impairment charge of $45.3 million recognized -

HOPKINTON, Mass., March 12 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), today reported its fourth quarter and full year financial results for 2008. Fourth quarter revenues were $36.7 million, a decline of 8.8%, from $40.3 million in the same period in 2007. This represents an organic decline of 2.0% after excluding the effects of product line divestitures (4.4%) and unfavorable effects of foreign currency translation (2.4%) within the fourth quarter. Caliper's GAAP net loss for the fourth quarter was $46.3 million ($0.95 per share), which includes $45.3 million ($0.93 per share) of non-cash goodwill impairment and other restructuring charges. This compares to a net loss of $5.7 million ($0.12 per share) in the same quarter of 2007. On a non-GAAP basis, which includes the adjustments noted in the attached reconciliation, net loss per share in the fourth quarter of 2008 was $0.02 compared to a net loss per share of $0.05 in the fourth quarter of 2007.

On March 6, 2009, Caliper entered into a $25 million amended credit facility agreement with Silicon Valley Bank, which is effective through November 30, 2010. As of December 31, 2008, Caliper reported cash and investments of $26.7 million and outstanding borrowings under this credit facility of $14.9 million.

"We were pleased to achieve the high end of our revenue guidance for the quarter and establish positive momentum in cash-based earnings. We achieved these results in spite of severe market conditions and earnings loss from the divested businesses," said Kevin Hrusovsky
'/>"/>

SOURCE Caliper Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
2. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
3. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
4. Caliper Enters Agreement to Divest Non-Core Pharmaceutical Development & Quality Analysis Product Line
5. Caliper Life Sciences Third Quarter 2008 Financial Results Conference Call Notice
6. Caliper Life Sciences and DiscoveRx Announce Availability of PathHunter eXpress Reagents for GPCR Assays
7. Caliper Life Sciences to Present at UBS Global Life Sciences Conference
8. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
9. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
10. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
11. Caliper Life Sciences Reports Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014   Niagara Thermal Products is proud ... BioBlower Technologies LLC ("B3") as the critical thermal component ... from the Army Corps of Engineers.  B3 has developed ... biological contaminants and destroys VOCs and other chemical pollutants, ...
(Date:1/15/2014)... Toronto, Canada (PRWEB) January 15, 2014 ... perspectives on nonclinical and clinical safety assessment in biosimilars. ... a path for biosimilar drug development, however the complex ... regards to quality, safety and efficacy extremely challenging. Based ...
(Date:1/15/2014)... 15, 2014 DTS Language Services, Inc ... Web Portal for Life Science organizations who need document translations. ... subject matter of their documents in advance with a selection ... time-to-delivery of translations, often a critical factor in clinical and ...
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: 6 p.m. – ... Warrington, Pa. , Details: The Hepatitis B Foundation, ... cure for hepatitis B and improving the quality of life ... on Friday, April 11 at Warrington Country Club in Warrington, ...
Breaking Biology Technology:Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... to Exceed $8 Billion Globally by 2012VENTURA, Calif., ... a continuous, integrated and wearable remote patient monitoring ... executive officer Howard Baker will present at the ... the Marines Memorial Club and Hotel in San ...
... 7 Nuvelo, Inc.,(Nasdaq: NUVO ) ... approved,the issuance of Nuvelo Common Stock pursuant to ... between Nuvelo, ARCA biopharma and a Nuvelo,subsidiary. Nuvelo,s ... until January 23, 2009, to solicit additional proxies ...
... settled in for the,winter months and since the common ... days of school and work, now is the time ... Immunity Enhanced Beverage is designed,to do just that. , ... Products, Immunity Enhanced,Beverage is a ready-to-drink liquid supplement intended ...
Cached Biology Technology:VivoMetrics to Present at the 2009 Biotech Showcase 2VivoMetrics to Present at the 2009 Biotech Showcase 3Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma 2Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma 3Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma 4Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma 5Innovative Beverage Products Launches New Product Designed to Enhance the Body's Immune Defense 2
(Date:7/9/2014)... Emerging fungal pathogens pose a greater threat to ... declines of amphibians, bats, corals, bees and snakes. ... published in the prestigious journal Nature ... resistance to a deadly chytrid fungus implicated in ... is important because it is the basis of ...
(Date:7/9/2014)... Rochelle, NY, July 9, 2014Biofuels derived from the oils ... to fossil fuels. To achieve this goal, optimization of ... in open pond systems, is needed. Sapphire Energy has ... of open pond algae cultivation systems, described in ... Liebert, Inc., publishers. The article is available on the ...
(Date:7/9/2014)... The Cancer Genome Atlas (TCGA) Research Network have ... in lung adenocarcinoma, the most common subtype of ... expand the number of possible therapeutic targets for ... of patients with treatable mutations because many potent ... , TCGA is jointly funded and managed by ...
Breaking Biology News(10 mins):USF study: Amphibians can acquire resistance to deadly fungus 2Controlling contamination in open algae ponds for biofuels 2Study identifies novel genomic changes in the most common type of lung cancer 2Study identifies novel genomic changes in the most common type of lung cancer 3
... potentially life-threatening challenge characterized by pauses in breathing that ... prematurity (AOP) affects more than 50 percent of premature ... preemies. Caused in part by an underdeveloped central nervous ... womb, especially during sleep, AOP is not yet fully ...
... or the American Chemical Society as publisher of this report. ... time in the United States, researchers are reporting in a ... fresh and canned food as well as food wrapped in ... almost 1,000 times lower than the "tolerable daily intake" levels ...
... study by the team headed by Llus Ribas de Pouplana, ... Barcelona), has been chosen as "Paper of the week" in ... , which is already available online. The article describes the ... melanogaster (fruit fly) that is crucial for mitochondria. The ...
Cached Biology News:UMass Medical School study points to genetic link in apnea of prematurity 2Scientists at IRB Barcelona discover a new protein critical for mitochondria 2
DAPI: 4', 6-Diamino-2-phenylindole dihydrochloride. Antifade Solution: p-Phenylenediamine and glycerol in PBS solution. 0.4g/mL DAPI suspended in Antifade....
... 13(S)-HODE-d4 contains 4 deuterium atoms at the ... intended for use as an internal standard for ... spectrometry. 13(S)-HODE is produced by incubation of linoleic ... been shown to inhibit the adhesion of tumor ...
...
...
Biology Products: